Tailored Helicobacter pylori eradication therapy based on prior exposure to Macrolide antibiotics: Prospective study
Not Applicable
Recruiting
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0007495
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Who are confirmed H. pylori infection and indicated for eradication, and consent to the provision of personal prescription information
Exclusion Criteria
Who do not understand the purpose of the study or do not consent to the examination
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The eradication rate of standard triple therapy in patients who have not taken macrolides, and the eradication rate of bismuth quadraple therapy in patients who have taken macrolides or have and eradication history
- Secondary Outcome Measures
Name Time Method Antibiotic resistance profile of H. pylori according to macrolide administration history